Project
Two cohort registry study for patients with advanced CSCC treated with Cemiplimab or other approaches
Ongoing - recruitment active ยท 2022 until 2025
Wagner Nikolaus
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2022
End Date
2025
Financing
Industry
Phase
IV